Real-Time Roadside Monitoring of Unreported VOC Emissions from Road Transport by SIFT-MS

This application note summarizes key SIFT-MS results presented in a peer reviewed article entitled “Unreported VOC Emissions from Road Transport Including from Electric Vehicles.” Learn how the Wolfson Atmospheric Chemistry Laboratory at the University of York used SIFT-MS for VOC analysis in its platform to experimentally verify that motor vehicle screen wash is a significant unreported source of VOC emissions (especially for ethanol and methanol).

Related Content

Advertisement

August 1st 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 1st 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 1st 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 1st 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 1st 2025

Success Guide – Marketing’s Final Mile

ACTO

August 1st 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO

Related Content

Advertisement

August 1st 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 1st 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 1st 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 1st 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 1st 2025

Success Guide – Marketing’s Final Mile

ACTO

August 1st 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO